Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Granulocyte colony-stimulating factor mobilized whole blood containing over 0.3 x 106/kg CD34+ cells is a sufficient graft in autologous transplantation for relapsed non-Hodgkin's lymphoma.
Jonkhoff AR, De Kreuk AM, Franschman G, Van Der Lelie J, Schuurhuis GJ, Dräger AM, Zweegman S, Huijgens PC, Ossenkoppele GJ. Jonkhoff AR, et al. Among authors: schuurhuis gj. Br J Haematol. 2002 Jul;118(1):90-100. doi: 10.1046/j.1365-2141.2002.03636.x. Br J Haematol. 2002. PMID: 12100131 Free article.
Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia.
van der Pol MA, Broxterman HJ, Pater JM, Feller N, van der Maas M, Weijers GW, Scheffer GL, Allen JD, Scheper RJ, van Loevezijn A, Ossenkoppele GJ, Schuurhuis GJ. van der Pol MA, et al. Among authors: schuurhuis gj. Haematologica. 2003 Feb;88(2):134-47. Haematologica. 2003. PMID: 12604403
Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients.
Feller N, van der Pol MA, Waaijman T, Weijers GW, Westra G, Ossenkoppele GJ, Schuurhuis GJ. Feller N, et al. Among authors: schuurhuis gj. Clin Cancer Res. 2005 Jul 1;11(13):4793-801. doi: 10.1158/1078-0432.CCR-05-0031. Clin Cancer Res. 2005. PMID: 16000576 Free article. Clinical Trial.
Inhibition of the intrinsic apoptosis pathway downstream of caspase-9 activation causes chemotherapy resistance in diffuse large B-cell lymphoma.
Cillessen SA, Hess CJ, Hooijberg E, Castricum KC, Kortman P, Denkers F, Vos W, van de Wiel MA, Schuurhuis GJ, Ossenkoppele GJ, Meijer CJ, Oudejans JJ. Cillessen SA, et al. Among authors: schuurhuis gj. Clin Cancer Res. 2007 Dec 1;13(23):7012-21. doi: 10.1158/1078-0432.CCR-06-2891. Clin Cancer Res. 2007. PMID: 18056177
175 results